A citation-based method for searching scientific literature

Hedvig Nordeng, Marleen M H J van Gelder, Olav Spigset, Gideon Koren, Adrienne Einarson, Malin Eberhard-Gran. J Clin Psychopharmacol 2012
Times Cited: 91







List of co-cited articles
623 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction.
Nancy K Grote, Jeffrey A Bridge, Amelia R Gavin, Jennifer L Melville, Satish Iyengar, Wayne J Katon. Arch Gen Psychiatry 2010
967
30

Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.
Lyn Colvin, Linda Slack-Smith, Fiona J Stanley, Carol Bower. Birth Defects Res A Clin Mol Teratol 2011
70
40

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
Lars Henning Pedersen, Tine Brink Henriksen, Mogens Vestergaard, Jørn Olsen, Bodil Hammer Bech. BMJ 2009
194
30

Use of antidepressant medications during pregnancy: a multisite study.
Susan E Andrade, Marsha A Raebel, Jeffrey Brown, Kimberly Lane, James Livingston, Denise Boudreau, Sharon J Rolnick, Douglas Roblin, David H Smith, Mary E Willy,[...]. Am J Obstet Gynecol 2008
265
29

Outcomes of prenatal antidepressant exposure.
Gregory E Simon, Michael L Cunningham, Robert L Davis. Am J Psychiatry 2002
244
28

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
Carol Louik, Angela E Lin, Martha M Werler, Sonia Hernández-Díaz, Allen A Mitchell. N Engl J Med 2007
347
28

Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
Heli Malm, Miia Artama, Mika Gissler, Annukka Ritvanen. Obstet Gynecol 2011
135
27

Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study.
Espen Jimenez-Solem, Jon Traerup Andersen, Morten Petersen, Kasper Broedbaek, Jonas Krogh Jensen, Shoaib Afzal, Gunnar H Gislason, Christian Torp-Pedersen, Henrik Enghusen Poulsen. BMJ Open 2012
90
27

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.
Robert L Davis, David Rubanowice, Heather McPhillips, Marsha A Raebel, Susan E Andrade, David Smith, Marianne Ulcickas Yood, Richard Platt. Pharmacoepidemiol Drug Saf 2007
132
26

Increasing use of antidepressants in pregnancy.
William O Cooper, Mary E Willy, Stephen J Pont, Wayne A Ray. Am J Obstet Gynecol 2007
323
26

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data.
Tim F Oberlander, William Warburton, Shaila Misri, Wayne Riggs, Jaafar Aghajanian, Clyde Hertzman. Birth Defects Res B Dev Reprod Toxicol 2008
130
26

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
Bengt A J Källén, Petra Otterblad Olausson. Birth Defects Res A Clin Mol Teratol 2007
181
26

Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
Hanan El Marroun, Vincent W V Jaddoe, James J Hudziak, Sabine J Roza, Eric A P Steegers, Albert Hofman, Frank C Verhulst, Tonya J H White, Bruno H C Stricker, Henning Tiemeier. Arch Gen Psychiatry 2012
112
25

Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis.
Jette B Kornum, Rikke B Nielsen, Lars Pedersen, Preben B Mortensen, Mette Nørgaard. Clin Epidemiol 2010
83
27

Antidepressant use in pregnancy and the risk of cardiac defects.
Krista F Huybrechts, Kristin Palmsten, Jerry Avorn, Lee S Cohen, Lewis B Holmes, Jessica M Franklin, Helen Mogun, Raisa Levin, Mary Kowal, Soko Setoguchi,[...]. N Engl J Med 2014
179
25

Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.
Rita Suri, Lori Altshuler, Gerhard Hellemann, Vivien K Burt, Ana Aquino, Jim Mintz. Am J Psychiatry 2007
173
24

Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
Katherine L Wisner, Dorothy K Y Sit, Barbara H Hanusa, Eydie L Moses-Kolko, Debra L Bogen, Diane F Hunker, James M Perel, Sonya Jones-Ivy, Lisa M Bodnar, Lynn T Singer. Am J Psychiatry 2009
262
24

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.
Lee S Cohen, Lori L Altshuler, Bernard L Harlow, Ruta Nonacs, D Jeffrey Newport, Adele C Viguera, Rita Suri, Vivien K Burt, Victoria Hendrick, Alison M Reminick,[...]. JAMA 2006
565
24

Birth outcomes in pregnant women taking fluoxetine.
C D Chambers, K A Johnson, L M Dick, R J Felix, K L Jones. N Engl J Med 1996
517
23

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
Anick Bérard, Elodie Ramos, Evelyne Rey, Lucie Blais, Martin St-André, Driss Oraichi. Birth Defects Res B Dev Reprod Toxicol 2007
180
23

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
Sura Alwan, Jennita Reefhuis, Sonja A Rasmussen, Richard S Olney, Jan M Friedman. N Engl J Med 2007
315
23

Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
Najaaraq Lund, Lars H Pedersen, Tine Brink Henriksen. Arch Pediatr Adolesc Med 2009
97
21

Selective serotonin reuptake inhibitors and adverse pregnancy outcomes.
Shi Wu Wen, Qiuying Yang, Peter Garner, William Fraser, Olufemi Olatunbosun, Carl Nimrod, Mark Walker. Am J Obstet Gynecol 2006
149
21

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.
Kimberly A Yonkers, Errol R Norwitz, Megan V Smith, Charles J Lockwood, Nathan Gotman, Edward Luchansky, Haiqun Lin, Kathleen Belanger. Epidemiology 2012
53
35

Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.
Regina C Casper, Barry E Fleisher, Julie C Lee-Ancajas, Allyson Gilles, Erika Gaylor, Anne DeBattista, H Eugene Hoyme. J Pediatr 2003
272
20

Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
Kari Furu, Helle Kieler, Bengt Haglund, Anders Engeland, Randi Selmer, Olof Stephansson, Unnur Anna Valdimarsdottir, Helga Zoega, Miia Artama, Mika Gissler,[...]. BMJ 2015
102
20

Risks associated with selective serotonin reuptake inhibitors in pregnancy.
Heli Malm, Timo Klaukka, Pertti J Neuvonen. Obstet Gynecol 2005
140
19

Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
Helle Kieler, Miia Artama, Anders Engeland, Orjan Ericsson, Kari Furu, Mika Gissler, Rikke Beck Nielsen, Mette Nørgaard, Olof Stephansson, Unnur Valdimarsdottir,[...]. BMJ 2012
169
19

Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.
Irena Nulman, Joanne Rovet, Donna E Stewart, Jacob Wolpin, Pia Pace-Asciak, Samar Shuhaiber, Gideon Koren. Am J Psychiatry 2002
265
19

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
N A Kulin, A Pastuszak, S R Sage, B Schick-Boschetto, G Spivey, M Feldkamp, K Ormond, D Matsui, A K Stein-Schechman, L Cook,[...]. JAMA 1998
313
18

Neurodevelopment of children exposed in utero to antidepressant drugs.
I Nulman, J Rovet, D E Stewart, J Wolpin, H A Gardner, J G Theis, N Kulin, G Koren. N Engl J Med 1997
372
18

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
Christina D Chambers, Sonia Hernandez-Diaz, Linda J Van Marter, Martha M Werler, Carol Louik, Kenneth Lyons Jones, Allen A Mitchell. N Engl J Med 2006
497
18

Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
Orna Diav-Citrin, Svetlana Shechtman, Dafna Weinbaum, Rebecka Wajnberg, Meytal Avgil, Elena Di Gianantonio, Maurizio Clementi, Corinna Weber-Schoendorfer, Christof Schaefer, Asher Ornoy. Br J Clin Pharmacol 2008
134
18

Use of antidepressants during pregnancy and the risk of spontaneous abortion.
Hamid Reza Nakhai-Pour, Perrine Broy, Anick Bérard. CMAJ 2010
101
18

Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis.
Lori E Ross, Sophie Grigoriadis, Lana Mamisashvili, Emily H Vonderporten, Michael Roerecke, Jürgen Rehm, Cindy-Lee Dennis, Gideon Koren, Meir Steiner, Patricia Mousmanis,[...]. JAMA Psychiatry 2013
156
18

Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Irena Nulman, Gideon Koren, Joanne Rovet, Maru Barrera, Ariel Pulver, David Streiner, Brian Feldman. Am J Psychiatry 2012
115
17

Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
Luke E Grzeskowiak, Andrew L Gilbert, Janna L Morrison. J Clin Psychopharmacol 2012
39
41

Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD.
Andrea V Margulis, Adel Abou-Ali, Marian M Strazzeri, Yulan Ding, Fatmatta Kuyateh, Eric Y Frimpong, Mark S Levenson, Tarek A Hammad. Pharmacoepidemiol Drug Saf 2013
34
47

Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.
L Ban, J E Gibson, J West, L Fiaschi, R Sokal, L Smeeth, P Doyle, R B Hubbard, L J Tata. BJOG 2014
52
30

Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur.
Paul Merlob, Einat Birk, Lea Sirota, Nehama Linder, Michael Berant, Bracha Stahl, Gil Klinger. Birth Defects Res A Clin Mol Teratol 2009
51
29

Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)
A Pastuszak, B Schick-Boschetto, C Zuber, M Feldkamp, M Pinelli, S Sihn, A Donnenfeld, M McCormack, M Leen-Mitchell, C Woodland. JAMA 1993
301
15

Antidepressant use during pregnancy and childhood autism spectrum disorders.
Lisa A Croen, Judith K Grether, Cathleen K Yoshida, Roxana Odouli, Victoria Hendrick. Arch Gen Psychiatry 2011
293
15

Prevalence of depression during pregnancy: systematic review.
Heather A Bennett, Adrienne Einarson, Anna Taddio, Gideon Koren, Thomas R Einarson. Obstet Gynecol 2004
962
15

Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study.
Chagit Klieger-Grossmann, Brenda Weitzner, Alice Panchaud, Alessandra Pistelli, Thomas Einarson, Gideon Koren, Adrienne Einarson. J Clin Pharmacol 2012
35
40


First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.
Keele E Wurst, Charles Poole, Sara A Ephross, Andrew F Olshan. Birth Defects Res A Clin Mol Teratol 2010
97
14

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Benjamin Bar-Oz, Thomas Einarson, Adrienne Einarson, Radinka Boskovic, Lisa O'Brien, Heli Malm, Anick Bérard, Gideon Koren. Clin Ther 2007
143
14

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.
Pia Wogelius, Mette Nørgaard, Mette Gislum, Lars Pedersen, Estrid Munk, Preben Bo Mortensen, Loren Lipworth, Henrik Toft Sørensen. Epidemiology 2006
137
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.